Inflammation, Cholesterol, and Stroke Risk: Building Evidence for a Dual Target Strategy for Secondary Prevention

Stroke. 2021 Aug;52(9):2837-2838. doi: 10.1161/STROKEAHA.121.035676. Epub 2021 Jul 20.

Authors

John J McCabe¹, Peter J Kelly¹

Affiliation

¹ Health Research Board Stroke Clinical Trials Network Ireland, University College Dublin, Ireland. Stroke Service, Mater Misericordiae University Hospital, Dublin, Ireland.

PMID: 34281382
DOI: 10.1161/STROKEAHA.121.035676

No abstract available

Keywords: C-reactive protein; Editorials; atrial fibrillation; humans; inflammation.

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Cholesterol
Humans
Inflammation / epidemiology
Secondary Prevention
Stroke* / epidemiology
Stroke* / prevention & control

Substances

Anticoagulants
Cholesterol